Doug Hampton

Waters et Sartorius élargissent le champ de leur collaboration afin d’offrir une bioanalyse complète pour la fabrication en aval de produits biologiques USA – Français USA – español APAC – English USA – Deutsch USA – English USA – English

by

Résumé de l’article : Intégration de la chromatographie multicolonnes à l’échelle des procédés de Sartorius à la technologie analytique des procédés de Waters afin de fournir des données analytiques solides pour la biofabrication en aval d’AcM, de protéines recombinantes, de vaccins et d’autres produits biologiques. Cette solution intégrée permet d’obtenir des données analytiques essentielles en quelques … Read more

BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK

by

LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly-designated Series I Preferred Stock, par value $0.001 per share, for each outstanding share of BIOLASE common stock held of … Read more

Children’s Hospital of Philadelphia Celebrates 27th Annual Fetal Surgery Family Reunion at the Philadelphia Zoo

by

PHILADELPHIA, June 5, 2023 /PRNewswire/ — Yesterday, more than 3,000 people gathered at the Philadelphia Zoo to celebrate the 27th Children’s Hospital of Philadelphia (CHOP) Fetal Family Reunion, representing patients and families from across the country. The event, hosted by CHOP’s Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT), provides an opportunity for those treated … Read more

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

by

CAMBRIDGE, Mass., June 5, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective June 1, 2023, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 7,593 shares of its common stock and an aggregate of 3,796 restricted stock units (RSUs) to six new … Read more

Greenbrook TMS Announces Receipt of Statement of Claim

by

TORONTO, June 5, 2023 /PRNewswire/ – Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company“) announced today that the sellers of Check Five LLC (d/b/a “Success TMS”) (“Success TMS“) have filed a complaint in the Superior Court of the State of Delaware against the Company, TMS NeuroHealth Centers, Inc. (“TMS NeuroHealth Centers“) and certain executive … Read more

Nevro Names New Chief Commercial Officer

by

Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus Company Updates Second Quarter 2023 Revenue Guidance REDWOOD CITY, Calif., June 5, 2023 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Greg Siller has been appointed Senior … Read more

FOUNDATION OF HOPE GIVES ALMOST $1 MILLION TO MENTAL ILLNESS RESEARCH

by

RALEIGH, N.C., June 5, 2023 /PRNewswire/ — Continuing efforts to curb the debilitating effects of mental illness, the Foundation of Hope for Research and Treatment of Mental Illness (FOH) has approved over $987,000 in research grants to fourteen investigators in the Department of Psychiatry at The University of North Carolina at Chapel Hill. The recipients … Read more

VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock

by

HENDERSON, Nev., June 5, 2023 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, announced today the closing of its previously announced underwritten public offering of its common stock generating gross proceeds to Volition from the offering of approximately $16.5 million, before deducting underwriting commissions and other offering expenses payable by Volition. All … Read more

On Lok Partners with San Francisco Health Plan to provide Enhanced Care Management to Eligible Medi-Cal Enrollees

by

SAN FRANCISCO, June 5, 2023 /PRNewswire/ — On Lok is partnering with San Francisco Health Plan (SFHP) to provide Enhanced Care Management (ECM) to SFHP members starting May 1. A new Medi-Cal benefit offered through CalAIM (California Advancing and Innovating Medi-Cal), ECM provides intensive coordination of health and health-related services to high-risk enrollees. CalAIM is … Read more

MEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Line Regimen in HR+/HER2- Advanced Breast Cancer Patients

by

JERSEY CITY, N.J., June 5, 2023 /PRNewswire/ — MEDSIR announced today the results of the PALMIRA trial. This randomized phase 2 study evaluated the safety and efficacy of palbociclib maintenance in combination with second-line endocrine therapy in patients with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer who had showed a confirmed progressive disease on first-line palbociclib … Read more